One of the listed companies, The IBN SINA Pharmaceutical Industry PLC discloses its financial reports for the third quarter, (July-September 23).
The company’s earnings per share (EPS) of Consolidated Tk 5.22 paisa in Q3 of the current financial year (July-September 23). Consolidated EPS was Tk 4.63 (restated) paisa during the same period last year. Consolidated NAV per share was Tk. 101.90 as on September 30, 2023.
Share this
